Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.7 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |